Prof. Patrizia Pontisso, MD, is an Associate Professor of Internal Medicine at the University of Padua, Department of Medicine, and is responsible for the Molecular Hepatology Laboratory and the Liver Biobank of the Regional Referral Center for Liver Diseases - Medical Clinic 5 at the Padua Teaching Hospital. She is a member of the European Association for the Study of the Liver (EASL) and of the Italian Association for the Study of the Liver (AISF), and was on the National AISF Board in 1999 and AISF National Secretary from 2000 to 2002. She is the author of more than 280 papers on peer reviewed medical journals. Total impact factor: 1911; Total citations 8212; H-Index Total: 48; Patent filed: 7.
Research fields: natural history and therapy of chronic liver diseases and liver tumors, mechanisms of carcinogenesis and new tumor markers, both in the biomolecular and in the nanotechnology fields, molecular studies on hepatitis B virus and hepatitis C virus, including genomic analysis and functional studies of viral proteins.
Research Keywords & Expertise
Cancer
Biomarkers discovery/d...
hepatocellular carcino...
Hepatology Biomedicine
serpinB3
Short Biography
Prof. Patrizia Pontisso, MD, is an Associate Professor of Internal Medicine at the University of Padua, Department of Medicine, and is responsible for the Molecular Hepatology Laboratory and the Liver Biobank of the Regional Referral Center for Liver Diseases - Medical Clinic 5 at the Padua Teaching Hospital. She is a member of the European Association for the Study of the Liver (EASL) and of the Italian Association for the Study of the Liver (AISF), and was on the National AISF Board in 1999 and AISF National Secretary from 2000 to 2002. She is the author of more than 280 papers on peer reviewed medical journals. Total impact factor: 1911; Total citations 8212; H-Index Total: 48; Patent filed: 7.
Research fields: natural history and therapy of chronic liver diseases and liver tumors, mechanisms of carcinogenesis and new tumor markers, both in the biomolecular and in the nanotechnology fields, molecular studies on hepatitis B virus and hepatitis C virus, including genomic analysis and functional studies of viral proteins.